Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease

Mohammad Khosravi(Delft University of Technology), Morteza Karimipoor(Pasteur Institute of Iran)
European Journal of Pharmacology
April 27, 2019
Cited by 68


Related Papers